GB
ABBV icon

Goepper Burkhardt’s AbbVie ABBV Stock Holding History

Goepper Burkhardt’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$801K Sell
3,181
-296
-9% -$63.7K 0.24% 47
2026
Q1 		$756K Buy
3,477
+2
+0.1% +$444 0.25% 48
2025
Q4 		$794K Buy
3,475
+2
+0.1% +$456 0.26% 46
2025
Q3 		$804K Sell
3,473
-99
-3% -$20.2K 0.27% 43
2025
Q2 		$663K Sell
3,572
-28
-0.8% -$5.2K 0.24% 49
2025
Q1 		$754K Buy
3,600
+46
+1% +$8.94K 0.3% 40
2024
Q4 		$632K Sell
3,554
-101
-3% -$18.6K 0.26% 43
2024
Q3 		$722K Hold
3,655
– – 0.3% 40
2024
Q2 		$627K Buy
3,655
+3
+0.1% +$497 0.28% 41
2024
Q1 		$587K Buy
3,652
+206
+6% +$35.5K 0.27% 44
2023
Q4 		$600K Buy
3,446
+36
+1% +$5.25K 0.3% 39
2023
Q3 		$508K Buy
3,410
+2
+0.1% +$294 0.31% 33
2023
Q2 		$459K Sell
3,408
-99
-3% -$14.5K 0.28% 37
2023
Q1 		$559K Buy
3,507
+1
+0% +$153 0.37% 28
2022
Q4 		$567K Buy
3,506
+67
+2% +$10.3K 0.4% 28
2022
Q3 		$462K Sell
3,439
-131
-4% -$18.8K 0.34% 30
2022
Q2 		$547K Buy
3,570
+433
+14% +$66.2K 0.39% 30
2022
Q1 		$509K Hold
3,137
– – 0.31% 35
2021
Q4 		$425K Buy
3,137
+1
+0% +$118 0.25% 41
2021
Q3 		$338K Buy
3,136
+1
+0% +$114 0.22% 46
2021
Q2 		$353K Buy
3,135
+85
+3% +$9.57K 0.22% 46
2021
Q1 		$330K Buy
3,050
+192
+7% +$20.5K 0.22% 45
2020
Q4 		$306K Buy
+2,858
New +$275K 0.22% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goepper Burkhardt's ABBV Position: Q2 2026 in Review

Goepper Burkhardt reduced its AbbVie (ABBV) stake by 8.5% in Q2 2026, selling an estimated $63.7K and leaving 3,181 shares worth $801K. The position accounts for 0.24% of the portfolio, ranked #47.

Goepper Burkhardt first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $804K in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Goepper Burkhardt held 3,181 shares of AbbVie worth $801K as of Q2 2026.
  • Goepper Burkhardt sold 296 AbbVie shares in Q2 2026, an estimated $63.7K.
  • AbbVie made up 0.24% of Goepper Burkhardt's portfolio in Q2 2026, its #47 holding.
  • Goepper Burkhardt first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Goepper Burkhardt's AbbVie position peaked at $804K in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Goepper Burkhardt's 13F filing for Q2 2026, filed 10 Aug 2026.